BRAF: A tool in the decision to perform elective neck dissection?

Thyroid

Volumn 23, Issue 12, 2013, Pages 1541-1546

  Dutenhefner, Simone E ^a   Marui, Suemi ^a   Santos, Andre B O ^a   De Lima, Erika Urbano ^a   Inoue, Milton ^a   Neto, Jose S Brandão ^a   Shiang, Christina ^a   Fukushima, Julia T ^a   Cernea, Claudio R ^a   Friguglietti, Celso U M ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Center for the Study of Thyroid Cancer (CECATIR)   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE;

ADULT; AGE; ARTICLE; CANCER PREVENTION; CONTROLLED STUDY; ELECTIVE SURGERY; FEMALE; GENE MUTATION; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; THYROIDECTOMY;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CARCINOMA, PAPILLARY; DECISION MAKING; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; NECK DISSECTION; PROTO-ONCOGENE PROTEINS B-RAF; THYROID NEOPLASMS; THYROIDECTOMY; YOUNG ADULT;

EID: 84880009159     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.0304     Document Type: Article

References (40)

1. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295: 2164-2167.
2. Leenhardt L, Grosclaude P, Cherie-Challine L 2004 Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 14: 1056-1060. (Pubitemid 40076130)
3. Mazzaferri EL 2006 An overview of the management of thyroid cancer. In: Mazzaferri EL, Harmer C, Mallick UK, Kendall-Taylor P, eds. Practical Management of Thyroid Cancer: A Multidisciplinary Approach. Springer-Verlag, London, United Kingdom, pp 1-28.
4. Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Horner MJ, Howlader N, Eisner MP, Reichman M, Edwards BK (eds). 2007 SEER Cancer Statistics Review, 1975-2004, National Cancer Institute. Bethesda, MD. Available at http://seer.cancer.gov/csr/1975-2004, based on November 2006 SEER data submission, posted to the SEER website, 2007.
5. Mazzaferri EL, Jhiang SM 1994 Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97: 418-428. (Pubitemid 24345593)
6. Xing M 2007 BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications. Endocr Rev 28: 742-762. (Pubitemid 350294294)
7. American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer; Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19: 1167-1214.
8. Pacini F, Schlumberger M, Dralle H, Elisei R, Smit JW, Wiersinga W; European Thyroid Cancer Taskforce 2006 European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol 154: 787-803. (Pubitemid 43997716)
9. Camargo R, Corigliano S, Friguglietti C, Gauna A, Harach R, Munizaga F, Niepomniszcze H, Pitoia F, Pretell E, Vaisman M, Ward LS, Wohllk N, Tomimori E; Latin American Thyroid Society 2009 Latin American thyroid society recommendations for the management of thyroid nodules. Arq Bras Endocrinol Metab 53: 1167-1175.
10. Mazzaferri EL, Doherty GM, Steward DL 2009 The pros and cons of prophylactic central compartment lymph node dissection for papillary thyroid carcinoma. Thyroid 19: 683-689.
11. Noguchi S, Noguchi A, Murakami N 1970 Papillary carcinoma of the thyroid. I. Developing pattern of metastasis. Cancer 26: 1053-1060.
12. Noguchi S, Noguchi A, Murakami N 1970 Papillary carcinoma of the thyroid. II. Value of prophylactic lymph node excision. Cancer 26: 1061-1064.
13. Kouvaraki MA, Shapiro SE, Fornage BD, Edeiken-Monro BS, Sherman SI, Vassilopoulou-Sellin R, Lee JE, Evans DB 2003 Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer. Surgery 134:946- 954, discussion 954-955.
14. Choi YJ, Yun JS, Kook SH, Jung EC, Park YL 2010 Clinical and imaging assessment of cervical lymph node metastasis in papillary thyroid carcinomas. World J Surg 34: 1494-1499.
15. O'Neill CJ, Bullock M, Chou A, Sidhu SB, Delbridge LW, Robinson BG, Gill AJ, Learoyd DL, Clifton-Bligh R, Sywak MS 2010 BRAF(V600E) mutation is associated with an increased risk of nodal recurrence requiring reoperative surgery in patients with thyroid cancer. Surgery 148:1139-1145; discussion 1145-1146.
16. Sykorova V, Dvorakova S, Ryska A, Vcelak J, Vaclavikova E, Laco J, Kodetova D, Kodet R, Cibula A, Duskova J, Hlobilkova A, Astl J, Vesely D, Betka J, Hoch J, Smutny S, Cap J, Vlcek P, Novak Z, Bendlova B 2010 BRAFV600E mutation in the pathogenesis of a large series of papillary thyroid carcinoma in Czech Republic. J Endocrinol Invest 33: 318-324.
17. Kwak JY, Kim EK, Chung WY, Moon HJ, Kim MJ, Choi JR 2009 Association of BRAFV600E mutation with poor clinical prognostic factors and US features in Korean patients with papillary thyroid microcarcinoma. Radiology 253: 854-860.
18. Oler G, Cerutti JM 2009 High prevalence of BRAF mutation in a Brazilian cohort of patients with sporadic papillary thyroid carcinomas: correlation with more aggressive phenotype and decreased expression of iodide-metabolizing genes. Cancer 115: 972-980.
19. Elisei R, Ugolini C, Viola D, Lupi C, Biagini A, Giannini R, Romei C, Miccoli P, Pinchera A, Basolo F 2008 BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study. J Clin Endocrinol Metab 93: 3943-3949.
20. Wang Y, Ji M, Wang W, Miao Z, Hou P, Chen X, Xu F, Zhu G, Sun X, Li Y, Condouris S, Liu D, Yan S, Pan J, Xing M 2008 Association of the T1799A BRAF mutation with tumor extrathyroidal invasion, higher peripheral platelet counts, and over-expression of platelet-derived growth factor-B in papillary thyroid cancer. Endocr Relat Cancer 15: 183-190. (Pubitemid 351449738)
21. Lupi C, Giannini R, Ugolini C, Proietti A, Berti P, Minuto M, Materazzi G,Elisei R, Santoro M, Miccoli P, Basolo F 2007 Association of BRAF V600E mutation with poor clinicopathological outcomes in 500 consecutive cases of papillary thyroid carcinoma. J Clin Endocrinol Metab 92: 4085-4090. (Pubitemid 350074715)
22. Kebebew E, Weng J, Bauer J, Ranvier G, Clark OH, Duh QY, Shibru D, Bastian B, Griffin A 2007 The prevalence and prognostic value of BRAF mutation in thyroid cancer Ann Surg 246: 466-470. (Pubitemid 47312140)
23. Rodolico V, Cabibi D, Pizzolanti G, Richiusa P, Gebbia N, Martorana A, Russo A, Amato MC, Galluzzo A, Giordano C 2007 BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid < or = 1 cm and their paired lymph node metastases. Cancer 110: 1218-1226. (Pubitemid 47435591)
24. Kim TY, Kim WB, Rhee YS, Song JY, Kim JM, Gong G, Lee S, Kim SY, Kim SC, Hong SJ, Shong YK 2006 The BRAF mutation is useful for prediction of clinical recurrence in lowrisk patients with conventional papillary thyroid carcinoma. Clin Endocrinol (Oxf) 65: 364-368.
25. Xing M, Westra WH, Tufano RP, Cohen Y, Rosenbaum E, Rhoden KJ, Carson KA, Vasko V, Larin A, Tallini G, Tolaney S, Holt EH, Hui P, Umbricht CB, Basaria S,Ewertz M, Tufaro AP, Califano JA, Ringel MD, Zeiger MA, Sidransky D, Ladenson PW 2005 BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab 90: 6373-6379. (Pubitemid 41759286)
26. Cibas ES, Ali SZ 2009 The Bethesda system for reporting thyroid cytopathology. Am J Clin Pathol 132: 658-665.
27. Orloff LA, Kuppersmith RB 2010 American Thyroid Association's central neck dissection terminology and classification for thyroid cancer consensus statement. Otolaryngol Head Neck Surg 142: 4-5.
28. Carty SE, Cooper DS, Doherty GM, Duh QY, Kloos RT, Mandel SJ, Randolph GW, Stack BC Jr, Steward DL, Terris DJ, Thompson GB, Tufano RP, Tuttle RM, Udelsman R 2009 Consensus statement on the terminology and classification of central neck dissection for thyroid cancer. Thyroid 19: 1153-1158.
29. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A 3rd (Eds) 2010 AJCC Cancer Staging Manual. 7th ed. Springer, New York.
30. Benlloch S, Payá A, Alenda C, Bessa X, Andreu M, Jover R, Castells A, Llor X, Aranda FI, Massutí B 2006 Detection of BRAF V600E mutation in colorectal cancer: comparison of automatic sequencing and real-time chemistry methodology. J Mol Diagn 8: 540-543. (Pubitemid 44774151)
31. Machens A, Hinze R, Thomusch O, Dralle H 2002 Pattern of nodal metastasis for primary and reoperative thyroid cancer. World J Surg 26: 22-28. (Pubitemid 36918813)
32. Lundgren CI, Hall P, Dickman PW, Zedenius J 2006 Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study. Cancer 106: 524-531. (Pubitemid 43157614)
33. Podnos YD, Smith D, Wagman LD, Ellenhorn JD 2005 The implication of lymph node metastasis on survival in patients with well-differentiated thyroid cancer. Am Surg 71: 731-734.
34. Zaydfudim V, Feurer ID, Griffin MR, Phay JE 2008 The impact of lymph node involvement on survival in patients with papillary and follicular thyroid carcinoma. Surgery 144:1070-1077; discussion 1077-1078.
35. Henry JF, Gramatica L, Denizot A, Kvachenyuk A, Puccini M, Defechereux T 1998 Morbidity of prophylactic lymph node dissection in the central neck area in patients with papillary thyroid carcinoma. Langenbecks Arch Surg 383: 167-169. (Pubitemid 28442533)
36. Bonnet S, Hartl D, Leboulleux S, Baudin E, Lumbroso JD, Al Ghuzlan A, Chami L, Schlumberger M, Travagli JP 2009 Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab 94: 1162-1667.
37. Salter KD, Andersen PE, Cohen JI, Schuff KG, Lester L, Shindo ML, Sauer D, Gross ND 2010 Central nodal metastases in papillary thyroid carcinoma based on tumor histologic type and focality. Arch Otolaryngol Head Neck Surg 136: 692-696.
38. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH 2003 Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer 98: 31-40. (Pubitemid 36741122)
39. Friguglietti CU, Dutenhefner SE, Brandão LG, Kulcsar MA 2011 Classification of papillary thyroid microcarcinoma according to size and fine-needle aspiration cytology: behavior and therapeutic implications. Head Neck 33: 696-701.
40. Sugino K, Kure Y, Iwasaki H, Ozaki O, Mimura T, Matsumoto A, Ito K 1995 Metastases to the regional lymph nodes, lymph node recurrence, and distant metastases in nonadvanced papillary thyroid carcinoma. Surg Today 25: 324-328.